Stockreport

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Entrada Therapeutics, Inc.  (TRDA) 
PDF Entrada Therapeutics, Inc. – Company on track to report ELEVATE-44-201 data from Cohort 1 in Q2 2026 and Cohort 2 by year-end 2026 – – Company on track to report EL [Read more]